Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...

GE HealthCare completes the $2.3B Intelerad deal to expand AI-driven imaging, boost recurring revenues and strengthen its cloud-first healthcare platform.

Moby summary of Tenon Medical, Inc.'s Q4 2025 earnings call ...

Tenon Medical, Inc. (NASDAQ:TNON) Q4 2025 Earnings Call Transcript March 19, 2026 Tenon Medical, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.36. Operator: Greetings ...

The Implications For Regulatory And IP Strategy. Legal News and Analysis - USA - Intellectual Property - Conventus Law ...

Thursday, March 19, 2026 at 4:30 p.m. ET Chief Executive Officer — Steven Foster Chief Financial Officer — Kevin Williamson Need a quote from a Motley Fool analyst? Email [email protected] Revenue -- $1.5 ...

In February, the US Food and Drug Administration granted 510(k) clearance to a dozen in vitro diagnostic tests encompassing molecular, immunoassay, clinical chemistry, and ion selective electrode ...

Q4 2025 Earnings Call March 19, 2026 4:30 PM EDTCompany ParticipantsSteven Foster - CEO, President & DirectorKevin ...

Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second Half ...

The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli Lilly.

Medical device industry veteran to lead expansion of Saberscope™, the market's first and only single-use video platform for minimally invasive surgery, laparoscopic procedures, and advanced surgical ...